| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.2M | +19.2% |
| Cost of Revenue | $21.1M | +36.7% |
| R&D Expense | $6.1M | -48.0% |
| SG&A Expense | $26.1M | -3.9% |
| Operating Income | -$12.2M | +39.4% |
| Pre-tax Income | -$14.4M | +27.8% |
| Net Income | -$14.4M | +27.8% |
| EPS (Basic) | -$1.31 | +33.2% |
| EPS (Diluted) | -$1.31 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.6M | +40.5% |
| Short-term Investments | $3.4M | — |
| Accounts Receivable | $4.0M | -33.8% |
| Inventory | $15.7M | +33.6% |
| Current Assets | $46.4M | +37.8% |
| Total Assets | $69.6M | +24.6% |
| Current Liabilities | $11.6M | +1.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.7M | +35.0% |
| Capital Expenditures | $236K | +105.2% |
| Investing Cash Flow | -$4.2M | -3513.9% |
| Financing Cash Flow | $19.8M | +1092.1% |
| Free Cash Flow | -$9.9M | +33.9% |
| +33.2% |
| Total Liabilities |
| $22.4M |
| +61.7% |
| Stockholders' Equity | $33.4M | -20.4% |